WallStreetZenWallStreetZen

NASDAQ: ARQT
Arcutis Biotherapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ARQT

Based on 4 analysts offering 12 month price targets for Arcutis Biotherapeutics Inc.
Min Forecast
$10.00+14.42%
Avg Forecast
$13.50+54.46%
Max Forecast
$17.00+94.51%

Should I buy or sell ARQT stock?

Based on 4 analysts offering ratings for Arcutis Biotherapeutics Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
1 analysts 25%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ARQT stock forecasts and price targets.

ARQT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-12
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2023-11-13

1 of 1

Forecast return on equity

Is ARQT forecast to generate an efficient return?
Company
N/A
Industry
-71.71%
Market
19.68%

Forecast return on assets

Is ARQT forecast to generate an efficient return on assets?
Company
N/A
Industry
7.14%

ARQT revenue forecast

What is ARQT's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$111.1M+86.43%
Avg 2 year Forecast
$228.6M+283.48%
Avg 3 year Forecast
$333.7M+459.78%
ARQT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ARQT revenue growth forecast

How is ARQT forecast to perform vs Biotechnology companies and vs the US market?
Company
94.05%
Industry
59.36%
Market
9.3%
ARQT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ARQT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ARQT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARQT$8.74$13.50+54.46%Strong Buy
ETNB$8.92$28.20+216.14%Buy
TYRA$16.38$25.50+55.68%Buy
TNGX$7.77$17.00+118.79%Strong Buy
KYTX$19.19$39.50+105.84%Strong Buy

Arcutis Biotherapeutics Stock Forecast FAQ

Is Arcutis Biotherapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: ARQT) stock is to Strong Buy ARQT stock.

Out of 4 analysts, 2 (50%) are recommending ARQT as a Strong Buy, 1 (25%) are recommending ARQT as a Buy, 1 (25%) are recommending ARQT as a Hold, 0 (0%) are recommending ARQT as a Sell, and 0 (0%) are recommending ARQT as a Strong Sell.

If you're new to stock investing, here's how to buy Arcutis Biotherapeutics stock.

What is ARQT's revenue growth forecast for 2024-2026?

(NASDAQ: ARQT) Arcutis Biotherapeutics's forecast annual revenue growth rate of 94.05% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.36%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.3%.

Arcutis Biotherapeutics's revenue in 2024 is $59,606,000.On average, 1 Wall Street analysts forecast ARQT's revenue for 2024 to be $10,758,288,150, with the lowest ARQT revenue forecast at $10,758,288,150, and the highest ARQT revenue forecast at $10,758,288,150. On average, 1 Wall Street analysts forecast ARQT's revenue for 2025 to be $22,129,308,074, with the lowest ARQT revenue forecast at $22,129,308,074, and the highest ARQT revenue forecast at $22,129,308,074.

In 2026, ARQT is forecast to generate $32,303,037,139 in revenue, with the lowest revenue forecast at $32,303,037,139 and the highest revenue forecast at $32,303,037,139.

What is ARQT's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: ARQT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 7.14%.

What is ARQT's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ARQT price target, the average ARQT price target is $13.50, with the highest ARQT stock price forecast at $17.00 and the lowest ARQT stock price forecast at $10.00.

On average, Wall Street analysts predict that Arcutis Biotherapeutics's share price could reach $13.50 by Apr 12, 2025. The average Arcutis Biotherapeutics stock price prediction forecasts a potential upside of 54.46% from the current ARQT share price of $8.74.

What is ARQT's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: ARQT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.